MedPath

Ketorzac

Brand Name: Ketorzac

Generic Name: Ketorolac Trometamol

Active
Registration Number

DRP-8857

Dosage Form

Solution For Injection (Iv/Im)

Issuance Date

November 2, 2024

Expiry Date

July 2, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength30mg/mL
Packaging1mL Type I hydrolytic class colorless borosilicate glass ampoule in PVC film Liner (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Non-Steroidal Anti-inflammatory (Acetic Acid Derivative Drug)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ketorolac TrometamolActive
Monograph: Ketorolac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform